On the one hand, the ROK-α expression was decreased by downregulating the activities of the Rho A/ROK-α and PKC-δ/MARCKS signal pathways, and the phosphorylation of PKC-δ and MARCKS was decreased by the interaction, thus alleviating cerebral ischemia cell damage. The gene discussed is PRKCD; the disease is brain ischemia.